Unilaterally and rapidly progressing white matter lesion and elevated cytokines in a patient with Tay-Sachs disease

Brain and Development

Volumn 32, Issue 3, 2010, Pages 244-247

  Hayase, Tomomi ^a   Shimizu, Jun ^a   Goto, Tamako ^a   Nozaki, Yasuyuki ^a   Mori, Masato ^a   Takahashi, Naoto ^a   Namba, Eiji ^b   Yamagata, Takanori ^a   Momoi, Mariko Y ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Cytokine; Dexamethasone; IL 5; MRI; Tay Sachs disease; TNF

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA N ACETYLHEXOSAMINIDASE ALPHA CHAIN; CREATINE KINASE; DEXAMETHASONE; GLYCEROL; LACTATE DEHYDROGENASE; MYELIN BASIC PROTEIN; PHENYTOIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRAIN DAMAGE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHOLESTEROL BLOOD LEVEL; CONVULSION; CREATINE KINASE BLOOD LEVEL; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HUMAN; HYPERSENSITIVITY; INTRON; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; SEIZURE; SIGNAL TRANSDUCTION; TAY SACHS DISEASE; THROMBOCYTE COUNT; UPPER RESPIRATORY TRACT INFECTION; WHITE MATTER;

ANTI-INFLAMMATORY AGENTS; CHILD, PRESCHOOL; CYTOKINES; DEXAMETHASONE; FEMALE; GLYCEROL; HUMANS; MAGNETIC RESONANCE IMAGING; NERVE FIBERS, MYELINATED; TAY-SACHS DISEASE;

EID: 77649185323     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2009.01.007     Document Type: Article

References (18)

1. Assadi M., Baseman S., Janson C., Wang D.J., Bilaniuk L., Leone P. Serial 1H-MRS in GM2 gangliosidoses. Eur J Pediatr 2008, 167:347-352.
2. Mugikura S., Takahashi S., Higano S., Kurihara N., Kon K., Sakamoto K. MR findings in Tay-Sachs disease. J Comput Assist Tomogr 1996, 20:551-555.
3. Fukumizu M., Yoshikawa H., Takashima S., Sakuragawa N., Kurokawa T. Tay-Sachs disease: progression of changes on neuroimaging in four cases. Neuroradiology 1992, 34:483-486.
4. Ozkara H.A., Topcu M. Sphingolipidoses in Turkey. Brain Dev 2004, 26:363-366.
5. Yoshikawa H., Yamada K., Sakuragawa N. MRI in the early stage of Tay-Sachs disease. Neuroradiology 1992, 34:394-395.
6. Huang J.Q., Trasler J.M., Igdoura S., Michaud J., Hanal N., Gravel R.A. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. Hum Mol Genet 1997, 6:1879-1885.
7. Tanaka A., Sakuraba H., Isshiki G., Suzuki K. The major mutation among Japanese patients with infantile Tay-Sachs disease aG-to-T transversion at the acceptor site of intron 5 of the beta-hexosaminidase alpha gene. Biochem Biophys Res Commun 1993, 30:539-546.
8. Auvin S., Devisme L., Maurage C.A., Soto-Ares G., Cuisset J.M., Leclerc F., et al. Neuropathological and MRI findings in an acute presentation of hemiconvulsion-hemiplegia: a report with pathophysiological implications. Seizure 2007, 16:371-376.
9. Mizuguchi M., Yamanouchi H., Ichiyama T., Shiomi M. Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand 2007, 115(Suppl 186):45-56.
10. Jeyakumar M., Thomas R., Elliot-Smith E., Smith D.A., van der Spoel A.C., d'Azzo A., et al. Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 2003, 126:974-987.
11. Wada R., TiVt C.J., Proia R.L. Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc Natl Acad Sci USA 2000, 97:10954-10959.
12. Myerowitz R., Lawson D., Mizukami H., Mi Y., Tifft C.J., Proia R.L. Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. Hum Mol Genet 2002, 11:1343-1350.
13. Tsuji D., Kuroki A., Ishibashi Y., Itakura T., Kuwahara J., Yamanaka S., et al. Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates. J Neurochem 2005, 92:1497-1507.
14. Wu Y.P., Proia R.L. Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice. Proc Natl Acad Sci USA 2004, 101:8425-8430.
15. Yamaguchi A., Katsuyama K., Nagahama K., Takai T., Aoki I., Yamanaka S. Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses. J Clin Invest 2004, 113:200-208.
16. Jeyakumar M., Smith D.A., Williams I.M., Borja M.C., Neville D.C., Butters T.D., et al. NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin. Ann Neurol 2004, 56:642-649.
17. Rothenberg M.E., Hogan S.P. The eosinophil. Annu Rev Immunol 2006, 24:147-174.
18. Itakura A., Kikuchi Y., Kouro T., Ikutani M., Takaki S., Askenase P.W., et al. Interleukin 5 plays an essential role in elicitation of contact sensitivity through dual effects on eosinophils and B-1 cells. Int Arch Allergy Immunol 2006, 140(Suppl 1):8-16.